- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07809958
Haptic Feedback for Improved Interoceptive Awareness and Mental Well-being
September 8, 2026 updated by: Massachusetts Institute of Technology
Haptic Feedback for Improved Interoceptive Awareness and Mental Well-being: A Comprehensive In-the-Wild Study for Wellness
This study investigates the relationship between heart-beat haptic feedback on interoceptive awareness and mental-wellbeing.
Previous research showed non-significant results in short-term emotion regulation tasks when given heartbeat haptic feedback, suggesting the need for an extended adjustment training period to build trust with interoceptive feedback systems.
To address this, the experimenters propose an in-the-wild study where participants wear a Bangle.js
smartwatch for one week each under two conditions: (1) Real heartbeat feedback and (2) Off-set heartbeat feedback.
This design aims to examine the influence of haptic feedback on psychological characteristics, including alexithymia, anhedonia, depression, anxiety, and general mental health.
The experimenters will also explore the usability and comfort levels related to prolonged wearable use, as well as the participants' ability to distinguish between real and off-set heartbeat feedback, particularly across different levels of alexithymia traits.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
29
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Cambridge, Massachusetts, United States, 02142
- MIT Media Lab
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- High alexithymia score at screening (TAS-20 >= 50)
Exclusion Criteria:
- Severe psychiatric condition
- Any type of heart arrythmia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Real heartrate feedback
Participants wear a smartwatch during all waking hours which delivers vibration pulses at a frequency matching the current heart rate sensed by the smartwatch
|
Participants wear a smartwatch during their waking hours which delivers pulses of vibration which can be matched to the frequency of the current heart rate (real condition) or heart rate from one hour ago (sham condition)
|
|
Sham Comparator: Sham heartrate feedback
Participants wear a smartwatch during all waking hours which delivers vibration pulses at a frequency matching the heart rate from one hour ago as measured by the smartwatch.
The time delay means that feedback does not match the current heartrate but maintains the overall descriptive statistics of the participant's heartbeat.
|
Participants wear a smartwatch during their waking hours which delivers pulses of vibration which can be matched to the frequency of the current heart rate (real condition) or heart rate from one hour ago (sham condition)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Center for Epidemiological Studies-Depression Scale
Time Frame: Difference from measurement at the start of each arm to end of each arm (1 week span)
|
Measured by the standard scoring procedure in each lab visit at the start of the week.
Decrease is considered an improvement.
|
Difference from measurement at the start of each arm to end of each arm (1 week span)
|
|
Interoceptive accuracy
Time Frame: 1 week (difference between SensHB at the start of each arm and the end of each arm)
|
Interoceptive accuracy measured using SensHb (slope of the correlation of estimated heart rate with smartwatch-recorded heart rate measured over three 1-minute measurement periods during the in-lab questionnaire)
|
1 week (difference between SensHB at the start of each arm and the end of each arm)
|
|
Snaith-Hamilton Pleasure Scale
Time Frame: Difference from measurement at the start of each arm to end of each arm (1 week span)
|
Measured at the lab visit at the start of each week.
We sum the pleasure rating for each item so the score represents overall hedonic capacity (opposite of anhedonia).
Increase is considered improvement
|
Difference from measurement at the start of each arm to end of each arm (1 week span)
|
|
General Anxiety Disorder-7 Anxiety Scale
Time Frame: Difference from measurement at the start of each arm to end of each arm (1 week span)
|
Measured by the standard scoring procedure in each lab visit at the start of the week.
Decrease is considered an improvement.
|
Difference from measurement at the start of each arm to end of each arm (1 week span)
|
|
Toronto Alexithymia Scale-20 Alexithymia Scale
Time Frame: Difference from measurement at the start of each arm to end of each arm (1 week span)
|
Measured by the standard scoring procedure in each lab visit at the start of the week.
Decrease is considered an improvement.
|
Difference from measurement at the start of each arm to end of each arm (1 week span)
|
|
General Health Questionnaire-12 General Mental Distress scale
Time Frame: Difference from measurement at the start of each arm to end of each arm (1 week span)
|
Measured by the standard scoring procedure in each lab visit at the start of the week.
Decrease is considered an improvement.
|
Difference from measurement at the start of each arm to end of each arm (1 week span)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Interoceptive confidence
Time Frame: 1 week (measure difference between start and end of each arm)
|
Self rated confidence in the accuracy of heartbeat count
|
1 week (measure difference between start and end of each arm)
|
|
Interoceptive awareness
Time Frame: Start of each arm to end of each arm (1 week)
|
Multidimensional Assessment of Interoceptive Awareness -2 total score.
Increase indicates improved interoceptive awareness.
|
Start of each arm to end of each arm (1 week)
|
|
Daily mood
Time Frame: 1 week (measured each day of the arm)
|
Brief Mood Introspection Scale (BMIS) positive-negative axis measured each day.
Increase indicates increased positive affect.
|
1 week (measured each day of the arm)
|
|
Daily mood variability
Time Frame: 1 week (measured each day of the arm)
|
Standard deviation of the Brief Mood Introspection Scale (BMIS) positive-negative mood axis across all the days in an arm.
Increase indicates increased emotional variability.
|
1 week (measured each day of the arm)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Pattie Maes, PhD, Massachusetts Institute of Technology
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 26, 2025
Primary Completion (Actual)
September 19, 2025
Study Completion (Actual)
September 19, 2025
Study Registration Dates
First Submitted
July 23, 2026
First Submitted That Met QC Criteria
September 8, 2026
First Posted (Actual)
September 9, 2026
Study Record Updates
Last Update Posted (Actual)
September 9, 2026
Last Update Submitted That Met QC Criteria
September 8, 2026
Last Verified
September 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2502001554
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Defidentified individual survey responses and sensHB accuracy data and analysis code
IPD Sharing Time Frame
Available indefinitely beginning March 2026
IPD Sharing Access Criteria
Data are available to the general public.
Data and analysis scripts can be found at https://osf.io/wfexj/overview
and the preregistered analysis plan can be found at https://aspredicted.org/hnyw-cw85.pdf
IPD Sharing Supporting Information Type
- SAP
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.